HIV-exposed uninfected children: A growing population with a vulnerable immune system?

Clinical and Experimental Immunology

Volumn 176, Issue 1, 2014, Pages 11-22

  Afran, L ^a,d   Garcia Knight, M ^b,e   Nduati, E ^e   Urban, B C ^c,e   Heyderman, R S ^d   Rowland Jones, S L ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF MALAWI   (Malawi)

^e KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

Author keywords

AIDS; Host pathogen interactions; Vaccination

Indexed keywords

ANTIRETROVIRUS AGENT;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE SYSTEM; MATERNAL CARE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PERINATAL PERIOD; PHENOTYPE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION;

AIDS; HOST-PATHOGEN INTERACTIONS; VACCINATION;

ANTIVIRAL AGENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SYSTEM; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84895543791     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12251     Document Type: Review

References (131)

1. Shapiro RL, Lockman S. Mortality among HIV-exposed infants: the first and final frontier. Clin Infect Dis 2010; 50:445-447.
2. Marinda E, Humphrey JH, Iliff PJ etal. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-526.
3. Koyanagi A, Humphrey JH, Ntozini R etal. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
4. Brahmbhatt H, Kigozi G, Wabwire-Mangen F etal. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2006; 41:504-508.
5. Landes M, van Lettow M, Chan AK, Mayuni I, Schouten EJ, Bedell RA. Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PLoS ONE 2012; 7:e47337.
6. Fawzy A, Arpadi S, Kankasa C etal. Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. J Infect Dis 2011; 203:1222-1230.
7. Slogrove A, Reikie B, Naidoo S etal. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012; 58:505-508.
8. Filteau S, Baisley K, Chisenga M, Kasonka L, Gibson RS. Provision of micronutrient-fortified food from 6 months of age does not permit HIV-exposed uninfected Zambian children to catch up in growth to HIV-unexposed children: a randomized controlled trial. J Acquir Immune Defic Syndr 2011; 56:166-175.
9. Liu L, Johnson HL, Cousens S etal. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379:2151-2161.
10. McNally LM, Jeena PM, Gajee K etal. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007; 369:1440-1451.
11. Slogrove AL, Cotton MF, Esser MM. Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency. J Trop Pediatr 2010; 56:75-81.
12. Singh HK, Gupte N, Kinikar A etal. High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants. BMC Infect Dis 2011; 11:193.
13. Epalza C, Goetghebuer T, Hainaut M etal. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:e631-638.
14. Lo YM, Lo ES, Watson N etal. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996; 88:4390-4395.
15. Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Transplacental transmission of human papillomavirus. Virol J 2008; 5:106.
16. Wright HT Jr. Congenital anomalies and viral infections in infants. The etiologic role of maternal viral infections. Calif Med 1966; 105:345-351.
17. Gaillard P, Verhofstede C, Mwanyumba F etal. Exposure to HIV-1 during delivery and mother-to-child transmission. AIDS 2000; 14:2341-2348.
18. Mano H, Chermann JC. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses 1991; 7:83-88.
19. Van de Perre P, Simonon A, Karita E etal. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 1993; 341:914-918.
20. Cameron PU, Lowe M, Sotzik F, Coughlan AF, Crowe SM, Shortman K. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J Exp Med 1996; 183:1851-1856.
21. Shapiro RL, Ndung'u T, Lockman S etal. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 2005; 192:713-719.
22. Pillay K, Coutsoudis A, York D, Kuhn L, Coovadia HM. Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr 2000; 24:330-336.
23. Richardson BA, John-Stewart GC, Hughes JP etal. Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis 2003; 187:736-740.
24. Rowland-Jones SL, Nixon DF, Aldhous MC etal. HIV-specific CTL activity in an HIV-exposed but uninfected infant. Lancet 1993; 341:860-861.
25. Cheynier R, Langlade-Demoyen P, Marescot M-R etal. Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1-infected mothers. Eur J Immunol 1992; 22:2211-2217.
26. Clerici M, Sison AV, Berzofsky JA etal. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993; 7:1427-1433.
27. Aldhous MC, Watret KC, Mok JY, Bird AG, Froebel KS. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol 1994; 97:61-67.
28. De Maria A, Cirillo C, Moretta L. Occurrence of HIV-specific CTL activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994; 170:1296-1299.
29. Legrand FA, Nixon DF, Loo CP etal. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLOS ONE 2006; 1:e102.
30. John-Stewart GC, Mbori-Ngacha D, Payne BL etal. HIV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. J Infect Dis 2009; 199:889-898.
31. Kuhn L, Coutsoudis A, Moodley D etal. T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission. AIDS 2001; 15:1-9.
32. Holditch SJ, Eriksson EM, Tarosso LF etal. Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants. Front Immunol 2011; 2:94.
33. Clerici M, Saresella M, Colombo F etal. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96:3866-3871.
34. Tiemessen CT, Shalekoff S, Meddows-Taylor S etal. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis 2010; 202:1444-1453.
35. Gesner M, Papaevangelou V, Kim M etal. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics 1994; 93:624-630.
36. Rich KC, Chang BH, Mofenson L etal. Elevated CD8+DR+ lymphocytes in HIV-exposed infants with early positive HIV cultures: a possible early marker of intrauterine transmission. Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:204-210.
37. Ono E, Nunes dos Santos AM, de Menezes Succi RC etal. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res 2008; 41:700-708.
38. Miles DJ, van der Sande M, Jeffries D etal. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol 2007; 81:5766-5776.
39. Miles DJ, van der Sande M, Jeffries D etal. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLOS ONE 2008; 3:e2905.
40. de Moraes-Pinto MI, Verhoeff F, Chimsuku L etal. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79:F202-205.
41. de MoraesPinto MI, Almeida ACM, Kenj G etal. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173:1077-1084.
42. Cumberland P, Shulman CE, Maple PA etal. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007; 196:550-557.
43. Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 2001; 345:1331-1335.
44. Bunders M, Pembrey L, Kuijpers T, Newell ML. Evidence of impact of maternal HIV infection on immunoglobulin levels in HIV-exposed uninfected children. AIDS Res Hum Retroviruses 2010; 26:967-975.
45. Scott S, Moss WJ, Cousens S etal. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 2007; 45:1417-1424.
46. Farquhar C, Nduati R, Haigwood N etal. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 2005; 40:494-497.
47. Hygino J, Lima PG, Filho RG etal. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol 2008; 127:340-347.
48. Hygino J, Vieira MM, Guillermo LV etal. Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women. J Clin Immunol 2011; 31:186-194.
49. Economides A, Schmid I, Anisman-Posner DJ, Plaeger S, Bryson YJ, Uittenbogaart CH. Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1998; 5:230-234.
50. Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012; 12:636-648.
51. Chougnet C, Kovacs A, Baker R etal. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 2000; 181:1590-1597.
52. Kuhn L, Kasonde P, Sinkala M etal. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005; 41:1654-1661.
53. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol 2008; 126:243-250.
54. Vigano A, Saresella M, Schenal M etal. Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers. AIDS 2007; 21:245-248.
55. Nielsen SD, Jeppesen DL, Kolte L etal. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
56. Kolte L, Rosenfeldt V, Vang L etal. Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 2011; 30:325-330.
57. Aaby P, Marx C, Trautner S etal. Thymus size at birth is associated with infant mortality: a community study from Guinea-Bissau. Acta Paediatr 2002; 91:698-703.
58. Garly ML, Trautner SL, Marx C etal. Thymus size at 6 months of age and subsequent child mortality. J Pediatr 2008; 153:683-688, 8 e1-3.
59. Romano MF, Buffolano W, Bisogni R etal. Increased CD154 expression in uninfected infants born to HIV-positive mothers exposed to antiretroviral prophylaxis. Viral Immunol 2006; 19:363-372.
60. Miyamoto M, Pessoa SD, Ono E etal. Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr 2010; 56:427-432.
61. Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol 1989; 142:3091-3097.
62. Chougnet C, Gessani S. Role of gp120 in dendritic cell dysfunction in HIV infection. J Leukoc Biol 2006; 80:994-1000.
63. Xu W, Santini PA, Sullivan JS etal. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009; 10:1008-1017.
64. Else LJ, Taylor S, Back DJ, Khoo SH. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid). Antivir Ther 2011; 16:1139-1147.
65. Venhoff N, Walker UA. Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf 2006; 5:373-381.
66. Kohler JJ, Lewis W. A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 2007; 48:166-172.
67. Blanche S, Tardieu M, Rustin P etal. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354:1084-1089.
68. Barret B, Tardieu M, Rustin P etal. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003; 17:1769-1785.
69. The Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000; 25:261-268.
70. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:380-387.
71. Brogly SB, DiMauro S, Van Dyke RB etal. Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children. AIDS Res Hum Retroviruses 2011; 27:777-783.
72. Aldrovandi GM, Chu C, Shearer WT etal. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 2009; 124:e1189-1197.
73. Poirier MC, Divi RL, Al-Harthi L etal. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003; 33:175-183.
74. Divi RL, Walker VE, Wade NA etal. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS 2004; 18:1013-1021.
75. Shiramizu B, Shikuma KM, Kamemoto L etal. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003; 32:370-374.
76. Giaquinto C, De Romeo A, Giacomet V etal. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. AIDS 2001; 15:1074-1075.
77. Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy. Pediatr Infect Dis J 2003; 22:782-789.
78. Noguera A, Fortuny C, Munoz-Almagro C etal. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals. Pediatrics 2004; 114:e598-603.
79. Ekouevi DK, Toure R, Becquet R etal. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: agence Nationale de Recherches Sur le SIDA et les Hepatites Virales 1209 study, Abidjan, Ivory Coast. Pediatrics 2006; 118:e1071-1077.
80. Lipshultz SE, Shearer WT, Thompson B etal. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol 2011; 57:76-85.
81. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 2003; 17:2053-2061.
82. Pacheco SE, McIntosh K, Lu M etal. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study. J Infect Dis 2006; 194:1089-1097.
83. Bunders M, Thorne C, Newell ML. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005; 19:1071-1079.
84. Study EC. Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS 2004; 18:2009-2017.
85. Feiterna-Sperling C, Weizsaecker K, Buhrer C etal. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr 2007; 45:43-51.
86. Lewis LD, Amin S, Civin CI, Lietman PS. Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production. Hum Exp Toxicol 2004; 23:173-185.
87. Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L. 3′-Azido-3′-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 1988; 69:299-304.
88. Andre-Schmutz I, Dal-Cortivo L, Six E etal. Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination. J Infect Dis 2013; 208:235-243.
89. Olivero OA, Torres LR, Gorjifard S etal. Perinatal exposure of Patas monkeys to antiretroviral nucleoside reverse-transcriptase inhibitors induces genotoxicity persistent for up to 3 years of age. J Infect Dis 2013; 208:244-248.
90. Schramm DB, Kuhn L, Gray GE, Tiemessen CT. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr 2006; 42:545-553.
91. Kuhn L, Meddows-Taylor S, Gray G etal. Reduced HIV-stimulated T helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission. Clin Exp Immunol 2001; 123:443-450.
92. Olivero OA. Relevance of experimental models for investigation of genotoxicity induced by antiretroviral therapy during human pregnancy. Mutat Res 2008; 658:184-190.
93. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576-584.
94. Reikie BA, Naidoo S, Ruck CE etal. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol 2013; 20:33-38.
95. Abramczuk BM, Mazzola TN, Moreno YM etal. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011; 18:1406-1409.
96. Sanz-Ramos M, Manno D, Kapambwe M etal. Reduced poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine 2013; 31:2042-2049.
97. Ota MO, O'Donovan D, Marchant A etal. HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a bacillus Calmette-Guérin scar. AIDS 1999; 13:996-998.
98. Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology 2010; 129:446-454.
99. Mazzola TN, da Silva MT, Abramczuk BM etal. Impaired bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants. AIDS 2011; 25:2079-2087.
100. Van Rie A, Madhi SA, Heera JR etal. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13:246-252.
101. Elliott AM, Mawa PA, Webb EL etal. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine 2010; 29:247-255.
102. Kagina BM, Abel B, Scriba TJ etal. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am J Respir Crit Care Med 2010; 182:1073-1079.
103. Kaye S, Miles D, Antoine P etal. Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. J Infect Dis 2008; 197:1307-1314.
104. Slyker JA, Lohman-Payne BL, Rowland-Jones SL etal. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS 2009; 23:117-124.
105. Duryea EL, Sanchez PJ, Sheffield JS etal. Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus. Pediatr Infect Dis J 2010; 29:915-918.
106. Bates M, Monze M, Bima H, Kapambwe M, Kasolo FC, Gompels UA. High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology 2008; 382:28-36.
107. Gompels UA, Larke N, Sanz-Ramos M etal. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 2012; 54:434-442.
108. Miles DJ, Sande M, Kaye S etal. CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study. J Infect Dis 2008; 197:658-662.
109. Slyker JA, Rowland-Jones SL, Dong T etal. Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants. J Virol 2012; 86:11373-11379.
110. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 2012; 12:330-340.
111. Broen K, Brustoski K, Engelmann I, Luty AJ. Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens. Mol Biochem Parasitol 2007; 151:1-8.
112. Metenou S, Suguitan AL Jr, Long C, Leke RG, Taylor DW. Fetal immune responses to Plasmodium falciparum antigens in a malaria-endemic region of Cameroon. J Immunol 2007; 178: 2770-2777.
113. King CL, Malhotra I, Wamachi A etal. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol 2002; 168:356-364.
114. Dent A, Malhotra I, Mungai P etal. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy. J Immunol 2006; 177:7139-7145.
115. Malhotra I, Dent A, Mungai P etal. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLOS Med 2009; 6:e1000116.
116. Steketee RW, Wirima JJ, Bloland PB etal. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42-49.
117. van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007; 212:475-490.
118. Malhotra I, Mungai P, Wamachi A etal. Helminth- and bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162:6843-6848.
119. Malhotra I, Mungai PL, Wamachi AN etal. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood. J Infect Dis 2006; 193:1005-1013.
120. Cuna WR, Choque AG, Passera R, Rodriguez C. Pro-inflammatory cytokine production in chagasic mothers and their uninfected newborns. J Parasitol 2009; 95:891-894.
121. Vekemans J, Truyens C, Torrico F etal. Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells to produce pro- and anti-inflammatory cytokines. Infect Immun 2000; 68:5430-5434.
122. Truyens C, Mjihdi K, Lambot MA, Rivera MT, Noel JC, Carlier Y. Effects of acute and chronic Trypanosoma cruzi infection in pregnant mice. Rev Soc Bras Med Trop 2005; 38 (Suppl. 2):68-72.
123. Koumbi L, Bertoletti A, Anastasiadou V etal. Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers. Cell Mol Immunol 2010; 7:454-458.
124. Rahman MJ, Degano IR, Singh M, Fernandez C. Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model. PLOS ONE 2010; 5:e9699.
125. Glennie SJ, Williams NA, Heyderman RS. Mucosal immunity in resource-limited setting: is the battle ground different? Trends Microbiol 2010; 18:487-493.
126. Borges-Almeida E, Milanez HM, Vilela MM et al. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect Dis 2011; 11:38. doi:10.1186/1471-2334-11-3
127. Mwiru R, Spiegelman D, Hertzmark E etal. Nutritional predictors of acute respiratory infections among children born to HIV-infected women in Tanzania. Journal of tropical pediatrics 2013; 59:203-208.
128. Nielsen SD, Jeppesen DL, Kolte L et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001; 98:398-404.
129. Miyamoto M, Pessoa SD, Ono E et al. Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. Journal of tropical pediatrics 2010; 56:427-432.
130. Blanche S, Tardieu M, Benhammou V, Warszawski J, Rustin P. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. Aids 2006; 20:1685-1690.
131. Aldrovandi GM, Chu C, Shearer WT et al. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 2009; 124:e1189-1197.